Publications on HIV PDR in the Mesoamerican Region, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Mesoamerican region. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in the Southern Cone, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the whole LAC region. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in the Caribbean, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis by Santiago Avila-Rios (3160959)

Subjects:

Number of significant genes and fold change. by Gordon A. Barr (11163243)

“…The effect of infant treatment on adult affective behavior showed a complex treatment by age dependent effect. Adult social behavior was decreased following Shock+mother pairings at both PN5-9 and PN10-14, whereas shock alone had no effect. …”

CpG/c stimulated CLL B cells decrease LEF-1 expression and increase PRDM1 expression. by Albert Gutierrez Jr. (342562)

Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases V1V2-specific IgG concentration and breadth. by LaTonya D. Williams (3140490)

Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

“…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”

<i>csrnp1a</i> knockdown decreases the number of blood cells in circulation. by Jaime Espina (106906)

“…(I) qPCR with primers located in exon 2 and 3 of 24 hpf control embryos (C) and splicing morphants injected with two concentrations, 2,5 and 5 ng per embryo, showing the relative expression of <i>csrnp1a</i> message, which decreases significantly in a dose-dependent manner (t student p<0,01).…”

S1 Fig - by Asadollahi Parisa (8837432)

Subjects:

Statistically significant correspondence between human psoriasis and mouse psoriasiform phenotypes: Proportion of psoriasiform-increased to psoriasiform-decreased transcripts. by William R. Swindell (175427)

“…<p>Genes significantly increased or decreased in human psoriasis were identified and the expression of orthologous genes was studied in the K5-Tie2 phenotype (A and B), the IMQ phenotype (C and D), the K14-AREG phenotype on ear skin (E and F), the K14-AREG phenotype on tail skin (G and H), the K5-Stat3C phenotype (I and J), and the K5-TGFβ1 phenotype (K and L). …”

A brief course of RAP treatment decreases markers of proliferation and increases markers of differentiation. by Karin M. Hardiman (555189)

“…(D) Alcian blue staining shows loss of most of the differentiated goblet cells in mouse polyps and RAP restore the goblet cell differentiation. (E) Immunostaining shows increased Sox9 (a cell fate marker) expression in polyps and RAP decreased the number of cells expressing Sox9. …”

Healthspan decreases in response to cell-associated factor LPS in a dose-dependent manner. by Gabriel M. Moore (8566113)

<i>IR52a</i> males are defective in sexual behavior. by Zhe He (508742)

Propagation of an action potential through ephaptic coupling is achieved for a decreased extracellular conductivity. by Karoline Horgmo Jæger (6785450)

Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort by Karina V. Grooteman (4050388)

R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study by Filip Fratev (1799740)

“…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”

R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study by Filip Fratev (1799740)

“…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”